Increased OPEC+ production also comes amid calls by Trump for the cartel to increase production and keep prices low. Trump ...

Investing.com-- U.S. President Donald Trump said on Wednesday that the House of Representatives was ready to vote on his “big ...

Trump also linked an article on Federal Housing Finance Agency Head Bill Pulte calling on Congress to investigate Fed Chair ...

Investing.com -- S&P Global Ratings has upgraded Bunge (NYSE: BG) Global S.A. to ’A-’ from ’BBB+’ following the completion of its merger with Viterra Ltd., removing the ratings from CreditWatch ...

Investing.com -- Zynex Inc (NASDAQ: ZYXI) stock dropped 5.6% after the medical technology company announced that Tricare, its largest insurance customer, will continue its temporary payment suspension ...

Investing.com -- National Beverage Corp. (NASDAQ: FIZZ) reported better-than-expected fourth quarter results, with earnings per share of $0.48, exceeding analyst estimates of $0.47, and revenue ...

Investing.com -- Franklin Covey Co . (NYSE: FC) reported a third-quarter loss that significantly missed analyst expectations, sending shares down as much as 6.5% as the organizational performance ...

Investing.com -- Inovio Pharmaceuticals Inc (NASDAQ: INO) stock plunged 14% after the company announced plans for an underwritten public offering of its common stock and warrants.

Investing.com -- Cytosorbents Corporation (NASDAQ: CTSO) stock plunged 23.5% after the blood purification therapy company received regulatory rejections for its DrugSorb-ATR device from both the U.S.

As part of its cryptocurrency strategy, Hyperion DeFi has launched a co-branded validator called ’Kinetiq x Hyperion’ and has begun staking its HYPE holdings to generate yield. The company’s CUSIP ...

Investing.com -- SolarWinds (NYSE: SWI) Corp has reached a settlement agreement in principle with the U.S. Securities and Exchange Commission regarding litigation connected to a Russia-linked ...

S&P could lower Oracle’s rating if debt to EBITDA remains above 3.5x over the next two years with no clear improvement path.